 Peripheral Arterial Disease
"Peripheral Arterial Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Descriptor ID |
D058729
|
| MeSH Number(s) |
C14.907.137.126.307.500 C14.907.617.671
|
| Concept/Terms |
Peripheral Arterial Disease- Peripheral Arterial Disease
- Arterial Disease, Peripheral
- Arterial Diseases, Peripheral
- Disease, Peripheral Arterial
- Diseases, Peripheral Arterial
- Peripheral Arterial Diseases
- Peripheral Artery Disease
- Artery Disease, Peripheral
- Artery Diseases, Peripheral
- Disease, Peripheral Artery
- Diseases, Peripheral Artery
- Peripheral Artery Diseases
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Arterial Disease".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Arterial Disease".
This graph shows the total number of publications written about "Peripheral Arterial Disease" by people in this website by year, and whether "Peripheral Arterial Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 | | 2010 | 5 | 0 | 5 | | 2011 | 5 | 0 | 5 | | 2012 | 6 | 2 | 8 | | 2013 | 8 | 1 | 9 | | 2014 | 8 | 1 | 9 | | 2015 | 15 | 2 | 17 | | 2016 | 15 | 0 | 15 | | 2017 | 21 | 1 | 22 | | 2018 | 19 | 3 | 22 | | 2019 | 20 | 3 | 23 | | 2020 | 33 | 1 | 34 | | 2021 | 32 | 0 | 32 | | 2022 | 29 | 0 | 29 | | 2023 | 19 | 0 | 19 | | 2024 | 21 | 3 | 24 | | 2025 | 17 | 1 | 18 | | 2026 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Peripheral Arterial Disease" by people in Profiles.
-
Gouda P, Secemsky EA, Hess CN, Arya S, Fokorede F, Mehran R, Bonaca MP, Patel MR, Jones WS. Secondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention. Am Heart J. 2026 Sep; 299:107446.
-
Canonico ME, Parr J, Debus ES, Nehler MR, Patel MR, Anand SS, Svet M, Hess CN, Capell WH, Ycas J, Chen J, Szarek M, Muehlhofer E, Haskell LP, Berkowitz SD, Bauersachs RM, Bonaca MP. Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial. Circ Cardiovasc Interv. 2026 May; 19(5):e015229.
-
Hogan S, Szarek M, Debus ES, Nehler M, Anand SS, Patel MR, Pap AF, Deng H, Hodge S, Haskell LP, Muehlhofer E, Berkowitz SE, Bauersachs RM, Bonaca MP. Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD. J Am Heart Assoc. 2025 Nov 04; 14(21):e039752.
-
Walker M, Riggs KA, Rohatgi A, Beckman J, Addo T, Girotra S, Bonaca MP, Armstrong E, Kumbhani DJ. Role of Lipids and Lipid Management Therapy Among Patients With Peripheral Artery Disease: A Reappraisal of the Current Evidence and Future Directions. J Am Heart Assoc. 2025 Oct 07; 14(19):e039734.
-
Aboyans V, Canonico ME, Chastaingt L, Anand SS, Brodmann M, Couffinhal T, Criqui MH, Debus ES, Mazzolai L, McDermott MM, Bonaca MP. Peripheral artery disease. Nat Rev Dis Primers. 2025 Sep 18; 11(1):68.
-
DeRubertis BG, Varcoe RL, Krishnan P, Bonaca MP, O'Connor DJ, Pin R, Metzger DC, Holden A, Lee JK, Iida O, Armstrong EJ, Kum SWC, Kolluri R, Bajakian DR, Garcia LA, Shishehbor MH, Yu S, Ruster K, Martinsen BJ, Igyarto Z, Parikh SA. Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial. Circulation. 2025 Oct 14; 152(15):1076-1086.
-
Rasouli N, Guder Arslan E, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Sourij H, Thomas S, Verma S, Bonaca MP. Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial. Diabetes Care. 2025 Sep 01; 48(9):1529-1535.
-
Verma S, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Thomas S, Nørgaard SK, Bonaca MP. Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease: The STRIDE Trial. J Am Coll Cardiol. 2025 Nov 18; 86(20):1843-1857.
-
McGinigle KL, Zhou CW, Freeman NLB, Conte MS, Strong MB, Barshes N, Bonaca M, Farber A, Rosenfield K, Menard MT. Anatomic profile of arterial occlusive disease in the BEST-CLI trial. J Vasc Surg. 2025 11; 82(5):1764-1769.
-
Muscoli S, Cimmino G, Canonico ME, Cesaro A, De Rosa G, De Rosa S, Coronelli MM, Natale F, Perrone MA, Sticchi A, Sorrentino S, Sucato V, Renda G, Paolillo S, Indolfi C, Calabrò P, Perrone Filardi P, Cirillo P. Comprehensive insights into peripheral artery disease: an overview from the working groups of pathogenesis of atherosclerosis and thrombosis of the Italian Society of Cardiology. J Cardiovasc Med (Hagerstown). 2025 07 01; 26(7):325-338.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|